Article
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
Oncotarget - 30 Mar 2015
Kopecka Joanna, Campia Ivana, Jacobs Andrea, Frei Andreas P, Ghigo Dario, Wollscheid Bernd, Riganti Chiara
Abstract excerpt
Multidrug resistance (MDR) in cancer cells is a challenging phenomenon often associated with P-glycoprotein (Pgp) surface expression. Finding new ways to bypass Pgp-mediated MDR still remains a daunting challenge towards the successful treatment of malignant neoplasms such as colorectal cancer.We applied the Cell Surface Capture technology to chemosensitive and chemoresistant human colon cancer to explore the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
